What is True Label?
True Label operates as a specialized provider of high-precision labeling solutions, catering primarily to the chemical and pharmaceutical industries. With a legacy spanning nearly three decades, the company distinguishes itself through the integration of advanced flexographic and digital printing technologies. Their operational model is built upon a zero-defect guarantee, ensuring that clients in mission-critical sectors receive labels that meet stringent regulatory and safety standards. By prioritizing rapid turnaround times and collaborative client engagement, True Label has established itself as a reliable partner in the industrial supply chain, effectively bridging the gap between complex manufacturing requirements and high-volume output needs.
How much funding has True Label raised?
True Label has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in True Label
PPP
Public-Private Partnership
What's next for True Label?
With the infusion of this late-stage capital, True Label is well-positioned to scale its technological infrastructure and expand its market reach. The strategic focus will likely shift toward enhancing digital printing capabilities to accommodate the increasing demand for variable data and personalized labeling in the healthcare sector. Furthermore, the company is expected to optimize its supply chain logistics to maintain its competitive edge in speed and service. As the firm navigates this growth phase, the emphasis will remain on maintaining the rigorous quality control standards that have defined its reputation, while potentially exploring new vertical markets that require the same level of technical expertise and regulatory adherence.
See full True Label company page
